home

Esmofir Educational Webinars 2016
Online Education

ESMOFIR will start in May 2016 to offer a series of educational webinars with various topics related to molecular and functional imaging.

Registration
ESMOFIR has planned 4 educational webinars for 2016. Each webinar will last approximately 50 minutes (40 min. presentation and 10 min. for discussion/questions). Registration for the online educational webinars will be free of charge and will be open to every interested participant.

Upcoming Webinars 2016

1. Therapy Monitoring in Oncology – RECIST and beyond
Monday, May 30, 2016 – 17:00 CEST
Dr. Clemens Cyran, Munich/DE
Kindly click here for your registration!

Description:

With the broad introduction of imaging-based therapy monitoring in oncology, criteria-based reporting methods were established to ensure standardized and reproducible results for response evaluation of oncologic patients in clinical studies. Response Evaluation Criteria in Solid Tumors (RECIST), as the most widely used morphological, size-based evaluation system, has been accepted by the FDA and the EMA for the definition of study endpoints within clinical trials based on the imaging assessment of change in tumor burden under primarily cytotoxic therapy. In recent years a broad range of novel molecular cancer therapeutics were introduced into clinical use. Among these are anti-angiogenic therapies, like tyrosine kinase inhibitors, which have shown their effectiveness in the treatment of several different tumor entities. These new therapy regimes demonstrated significant effects on tumor angiogenesis and tumor metabolism, but often only subtle effects on tumor morphology, particularly in early stages of tumor treatment. Established methods of monitoring cytotoxic tumor therapies, such as RECIST have been shown to be not sufficiently sensitive for monitoring the early therapeutic effects of molecular anti-cancer agents to allow for a timely differentiation of responders from non-responders.

The complementary acquisition of morphological, functional and molecular information using hybrid imaging techniques (PET/CT, PET/MRI) allows for a higher sensitivity and specificity in the detection of tumor manifestations and the timely differentiation of responders from non-responders using different tracers and in various tumor entities. Dedicated tracers such as [18F]-FDG, [68Ga]-DOTA-TATE, [68Ga]-PSMA und [18F]-DOPA allow for the visualization of glucose metabolism, tumor receptor and protein expression, or enzymatic activity, depending on indication and tumor entity. As novel cancer treatments allow for extended survival of frequently chronic tumor patients, modified response criteria are increasingly integrating functional imaging information (e.g. glucose metabolism in Cheson criteria/Lugano Classification) to further improve the standardized and reproducible assessment of therapy response by imaging studies.

Learning Objectives:

  • Clinically established morphological reporting criteria in therapy monitoring
  • Established functional imaging criteria in therapy monitoring
  • Innovations and future imaging techniques in monitoring therapy response

 

2. Functional Renal Imaging
Wednesday, June 29, 2016 – 17:00 CEST

Prof. Mike Notohamiprodjo, Tuebingen/DE

Description:

Renal Diseases often do not show morphological correlate in cross-sectional imaging. Functional imaging techniques assess renal function and ultrastructure beyond gross morphology. Contrast-enhanced techniques allow to quantify renal perfusion and filtration, whereas diffusion-weighted imaging methods investigate renal cellularity and microcirculation as well as tubular diffusion anisotropy. BOLD imaging can be used to probe the functional reserve of kidneys.

Learning Objectives:

  • Make the audience familiar with functional imaging techniques
  • Give an overview of potential clinical applications.

 

3. Breast Imaging
September 2016
Prof. Thomas Helbich, Vienna/AT

 

4. Radiomics: Imaging Meets Data
November 2016
Prof. Laure Fournier, Paris/FR

 

 

 

Esmofir Workshop 2016.2
multimodality hands-on workshop in breast imaging
from morphology to function and molecules

June 24-25, 2016
Vienna/AT

 

Workshop Registration

Kindly click here for your workshop registration.


Workshop Organiser

Thomas Helbich, Vienna/AT

Workshop Venue

ESR Office
Neutorgasse 9/2a
1010 Vienna
Austria

Course Overview

Breast cancer is the most common cancer in women with a stable incidence and a decrease in mortality, which is attributed to improved imaging and therapeutic options. Detection and characterization of breast cancer at an early stage is pivotal. Morphologic imaging is still of utmost importance. Nevertheless functional and molecular imaging techniques are assuming an increasingly important role in the non-invasive diagnosis and staging of breast tumors. In recent years there have been advances with regards to functional and molecular imaging in all breast imaging techniques such as mammography/ tomosynthesis, ultrasound, MRI, and nuclear medicine. Profound knowledge and understanding of current and emerging morphologic, functional, and molecular imaging modalities are warranted. This allows a deeper insight into tumor biology and represents one more step towards personalized medicine.
In 1.5 days this concise yet comprehensive workshop will provide an update on the state of the art as well as cutting edge technologies in breast imaging. Each modality-based session will also feature tutored hands-on teaching of clinical cases to maximize learning benefits in an interactive educational setting.

Learning Objectives

  •  Refresh your knowledge on state of the art breast imaging
  • Update your BIRADS knowledge
  • Understand available and emerging functional and molecular imaging techniques
  • Be able to build an imaging protocol taking into account the imaging goal and the imaging modality
  • Practice actively on real cases using different imaging techniques and learn to avoid pitfall

 

Preliminary Workshop Programme

Friday, June 24, 2016 | 13:30 – 17:40
13:30-13:45 Welcome and Introduction
T. Helbich, Vienna/AT
13:45-14:45 Mammography and Ultrasound: Morphology
13:45-14:15 State of the art mammography and BIRADS update
Eva M. Fallenberg, Berlin/DE
14:15-14:45 State of the art ultrasound and BIRADS update
Alexandra Athanasiou, Athen/GR
14:45-16:10 Function and Molecules
14:45-15:15 Contrast and non-contrast enhanced mammography / tomosynthesis
Eva M. Fallenberg, Berlin/DE
15:20-15:40 Coffee Break
15:40-16:10 From black and white imaging to elastography and CE – US
Alexandra Athanasiou, Athen/GR
16:10-17:40 Hands-on sessions: MG & US
16:10-16:55 Mammography / tomosynthesis
Eva M. Fallenberg, Berlin/DE
16:55-17:40 Ultrasound
Alexandra Athanasiou, Athen/GR

 

Saturday, June 25, 2016 | 08:30-17:00
08:30-10:00 MAGNETIC RESONANCE IMAGING – MRI
08:30-09:00 State of the art MRI
P. Baltzer, Vienna/AT
09:00-09:30 BIRADS update
T. Helbich, Vienna/AT
09:30-10:00 DWI, MRS, and reading algorithms
P. Baltzer, Vienna/AT
10:00-10:20 Coffee Break
10:20-10:40 Biomarker imaging with multiparametric MRI
T. Helbich, Vienna/AT
10:40-12:30 Hands-on sessions: MRI
10:40-11:25 MRI I
P. Baltzer, Vienna/AT
11:25-12:15 MRI II
T. Helbich, Vienna/AT
12:15-13:30 Lunch Break
13:30-15:00 SPECT, PET, and more
13:30-14:00 Tracers and their importance for breast imaging
Michel Herranz Carnero, Coruna/ES
14:00-14:30 Interventional procedures of the breast
T. Helbich, Vienna/AT
14:30-15:00 Breast imaging in nuclear medicine
Michel Herranz Carnero, Coruna/ES
15:00-15:20 Coffee Break
15:20-17:00 Hands-on sessions: NUC
15:20-16:20 NUC imaging
Michel Herranz Carnero, Coruna/ES
16:20-17:00 Quiz
T. Helbich, Vienna/AT
17:00 Closing Remarks
T. Helbich, Vienna/AT


Registration Fees

Early Fee (until May 6) Late Fee (May 6 – June 23)
Regular Non-Member € 370,00 € 470,00
Regular Member € 290,00 € 390,00
Resident Non-Member € 270,00 € 370,00
Resident Member € 190,00 € 290,00